Dalus, Nurmalyn .
HRN: 25-74-71 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2024
CEFUROXIME 1.5GM (VIAL)
08/27/2024
08/28/2024
IV
1.6gm 2 Doses
Q8
Post Cs
Waiting Final Action
08/27/2024
CEFUROXIME 500MG (TAB)
08/27/2024
09/02/2024
PO
500mg
BID
Post Cs
Waiting Final Action
08/28/2024
CEFUROXIME 500MG (TAB)
08/28/2024
09/03/2024
PO
500 Mg
BID
Sp 1 LTCS
Waiting Final Action